What procurement criteria should hospitals weigh when standardising on a single supplier in the Transcatheter Aortic Valve Replacement Market?

Prioritise sizing-matrix coverage for your patient anatomy mix over headline unit price. Single-supplier contracts that lack small-annulus or bicuspid options force off-contract purchases that erode the discount entirely [12]. Read More

How do capital equipment requirements affect entry for a new centre?

A hybrid operating room with fixed fluoroscopy runs USD 2.5–4 million before staffing. Centres performing under 50 cases annually rarely reach breakeven, which is why regulators attach volume thresholds to certification [2]. Read More

Which unmet clinical indication represents the largest untapped pool in the Transcatheter Aortic Valve Replacement Market?

While native aortic regurgitation historically lacked dedicated options, the FDA granted Premarket Approval to JenaValve's Trilogy System in March 2026, making it the first transcatheter device indicated for symptomatic severe AR in the U.S. Read More

How should investors read the widening gap between procedure volume growth and revenue growth?

Volume is outpacing revenue in Europe and Japan because tender pricing compresses faster than cases expand. Judge manufacturers on emerging-market share gains, not on unit shipments in mature geographies [8]. Read More

What integration challenges slow adoption of new valve platforms in the Transcatheter Aortic Valve Replacement Market?

Imaging workflow, not the device. Each platform uses proprietary sizing software and deployment landmarks, so switching costs sit in retraining imaging teams and revalidating CT protocols [17]. Read More

Does regulatory divergence between the FDA and EU Medical Device Regulation favour either region for launches?

Europe has lost its historical first-launch advantage. MDR clinical evidence requirements now approach FDA thresholds, and several manufacturers now file in the United States first [23]. Read More

How do bicuspid aortic valve patients change device selection?

Elliptical annuli and asymmetric calcification make standard sizing unreliable, raising paravalvular leak risk. Platforms with repositionability or purpose-built anchoring geometry are preferred, particularly across East Asian populations [9]. Read More

Transcatheter Aortic Valve Replacement Market (2026 - 2035)

Transcatheter Aortic Valve Replacement Market Research Report: Size, Share, Trend Analysis By Procedure Type (Self-Expanding Valve, Balloon-Expandable Valve, Transcatheter Aortic Valve), By Reference Type (Direct Access, Transfemoral, Transapical), By Material Type (Metal, Bioprosthetic, Hybrid), By End-user (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

9.6%

2025 Market Size

USD 7.02 Billion

2035 Market Size

USD 17.55 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/20244-HCR | Pages: 200 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Report Takeaways |
1. 2.1 Takeaways by Type of Device |
2. 2.2 Takeaways by End User |
3. 2.3 Takeaways by Region
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2024) |
2. 3.2 Base Year Assessment (2025) |
3. 3.3 Forecast Market Size (2026–2035) |
4. 3.4 Year-over-Year Growth Analysis
4 Market Dynamics — Driver Impact Analysis |
1. 4.1 Indication Expansion Into Low-Risk Patients |
2. 4.2 Reimbursement Architecture |
3. 4.3 Device Engineering and Durability |
4. 4.4 Asia-Pacific Capacity Expansion
5 Market Dynamics — Restraints Impact Analysis |
1. 5.1 Durability in Younger Patients |
2. 5.2 Conduction System Complications |
3. 5.3 Pricing Pressure and Hospital Economics
6 Market Opportunity Analysis |
1. 6.1 Ambulatory and Same-Day Discharge Pathways |
2. 6.2 Valve-in-Valve and Lifetime Management |
3. 6.3 Emerging Market Localisation |
4. 6.4 Registry Data and Outcome-Linked Contracting |
5. 6.5 Artificial Intelligence in Procedural Planning |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 United States | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 United Kingdom | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Algorithmic Procedural Planning |
2. 8.2 Lifetime Management as Product Strategy |
3. 8.3 Price Tiering and Portfolio Bifurcation |
4. 8.4 Evidence Infrastructure and Payer Accountability
9 Market Segmentation Analysis |
1. 9.1 By Type of Device | |
  1. 9.1.1 Self-Expanding Valves | |
  2. 9.1.2 Balloon-Expandable Valves | |
  3. 9.1.3 Mechanically Expandable and Other Valves |
2. 9.2 By Procedure | |
  1. 9.2.1 Transfemoral | |
  2. 9.2.2 Transapical | |
  3. 9.2.3 Transaortic |
3. 9.3 By Material | |
  1. 9.3.1 Nitinol | |
  2. 9.3.2 Cobalt Chromium | |
  3. 9.3.3 Stainless Steel and Other Alloys |
4. 9.4 By End User | |
  1. 9.4.1 Hospitals | |
  2. 9.4.2 Ambulatory Surgical Centres | |
  3. 9.4.3 Cardiac Specialty Centres and Others
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Edwards Lifesciences | |
  2. 10.3.2 Medtronic | |
  3. 10.3.3 Abbott Laboratories | |
  4. 10.3.4 Boston Scientific | |
  5. 10.3.5 Venus Medtech | |
  6. 10.3.6 Meril Life Sciences | |
  7. 10.3.7 JenaValve Technology | |
  8. 10.3.8 MicroPort Scientific | |
  9. 10.3.9 Peijia Medical | |
  10. 10.3.10 Braile Biomédica | |
  11. 10.3.11 Anteris Technologies
11 Recent News & Developments (2023–2025)
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Valuation Approach & Currency |
3. 12.3 Segment Coverage
13 Detailed Sources & Citations |
1. 13.1 Primary Research Inputs |
2. 13.2 Secondary Data Sources |
3. 13.3 Abbreviations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Transcatheter Aortic Valve Replacement Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis Matrix, 2026–2035 |
TABLE 4 Restraint Impact Analysis Matrix, 2026–2035 |
TABLE 5 Global Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 Regional Summary — Share, CAGR and Investment Themes, 2025 |
TABLE 7 North America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Europe Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 South America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Global Market Size, by Type of Device, 2021–2035 (USD Billion) |
TABLE 13 Global Market Size, by Procedure, 2021–2035 (USD Billion) |
TABLE 14 Global Market Size, by Material, 2021–2035 (USD Billion) |
TABLE 15 Global Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 16 North America Market Size, by Type of Device and End User, 2021–2035 (USD Billion) |
TABLE 17 Europe Market Size, by Type of Device and Procedure, 2021–2035 (USD Billion) |
TABLE 18 Asia-Pacific Market Size, by Type of Device and End User, 2021–2035 (USD Billion) |
TABLE 19 South America Market Size, by Procedure and End User, 2021–2035 (USD Billion) |
TABLE 20 Middle East & Africa Market Size, by Type of Device and End User, 2021–2035 (USD Billion) |
TABLE 21 Competitive Benchmarking Matrix, 2026 |
TABLE 22 Company Profiles — Key Players and Revenue Share Ranges |
TABLE 23 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 24 Report Scope & Methodology Summary |
TABLE 25 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Market Dynamics Overview — Drivers, Restraints and Opportunities |
FIGURE 2 Industry Value Chain Analysis — Tissue Sourcing to Procedure Delivery |
FIGURE 3 Porter's Five Forces Analysis |
FIGURE 4 Global Market Size Trend and Forecast Curve, 2021–2035 |
FIGURE 5 Year-over-Year Growth Trajectory, 2022–2035 |
FIGURE 6 Market Share by Type of Device, 2025 vs 2035 |
FIGURE 7 Market Share by Procedure, 2025 vs 2035 |
FIGURE 8 Market Share by Material, 2025 |
FIGURE 9 Market Share by End User, 2025 vs 2035 |
FIGURE 10 Regional Market Share Distribution, 2025 |
FIGURE 11 Regional CAGR Comparison, 2026–2035 |
FIGURE 12 Country-Level Growth Heat Map, Asia-Pacific |
FIGURE 13 Competitive Landscape — Estimated Revenue Share Bands, 2026 |
FIGURE 14 Strategic Positioning Matrix — Evidence Depth vs Price Tier |
FIGURE 15 Reimbursement Maturity vs Procedure Penetration by Country

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Type of Device	Self-Expanding Valves; Balloon-Expandable Valves; Mechanically Expandable and Other Valves	Balloon-Expandable Valves	Self-Expanding Valves
By Procedure	Transfemoral; Transapical; Transaortic	Transfemoral	Transfemoral
By Material	Nitinol; Cobalt Chromium; Stainless Steel and Other Alloys	Nitinol	Nitinol
By End User	Hospitals; Ambulatory Surgical Centres; Cardiac Specialty Centres and Others	Hospitals	Ambulatory Surgical Centres
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Type of Device

Sub-Segment	Key Trend
Self-Expanding Valves	Supra-annular design gains share in small-annulus and bicuspid anatomy
Balloon-Expandable Valves	Retains majority volume due to operator familiarity and lower pacemaker rates
Mechanically Expandable and Other Valves	Niche use where full repositionability is clinically required

Device architecture is the primary axis of competition. Balloon-expandable platforms hold the installed base, but self-expanding designs are closing the gap wherever effective orifice area in small annuli determines outcomes — a segment that skews toward female and Asian patient populations.

By Procedure

Sub-Segment	Key Trend
Transfemoral	Sheath miniaturisation lifts suitability above 92% of screened candidates
Transapical	Declining share as femoral access becomes viable in more anatomies
Transaortic	Retained for porcelain aorta and hostile iliofemoral disease

Access route has effectively consolidated. Transfemoral procedures now define the standard of care, and alternative access persists as clinical insurance rather than as a growth segment.

By Material

Sub-Segment	Key Trend
Nitinol	Shape-memory conformability underpins self-expanding frame growth
Cobalt Chromium	Thin-strut radial strength enables low frame heights and coronary re-access
Stainless Steel and Other Alloys	Legacy platforms and specialty geometries in regional markets

Frame material tracks expansion mechanism almost one-to-one. The design conversation is shifting from strength to sequencing, with alloys evaluated on whether they preserve options for a second valve a decade later.

By End User

Sub-Segment	Key Trend
Hospitals	On-site surgical backup requirements lock in majority volume
Ambulatory Surgical Centres	Same-day discharge and cost differentials drive fastest growth
Cardiac Specialty Centres and Others	Focused-factory models improve throughput and per-case economics

Care setting is where economics, not clinical evidence, decides the outcome. Payer willingness to relax site-of-service restrictions will determine how quickly ambulatory volume scales beyond its current low-teens share.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”